Dr. Annette Stemhagen – DIA 2020 Inspire Award Winner
UBC’s Dr. Annette Stemhagen received well-deserved recognition at the 2020 DIA Global Annual Meeting.
Racial Injustice Will Not Be Tolerated
Amid the current health crisis, we are now facing the pain and heartache of the senseless killing of George Floyd.
The Essential Role of Real World Evidence Combating COVID-19
Are you prepared for potential accelerated approval requirements?
ISPE’s Position on Real World Evidence (RWE)
Read more about the February 2020 position on RWE from ISPE.
Lack of Label Alignment & Patient Safety Implications
Read the full article from UBC’s pharmacovigilance team in Drugs Real World Outcomes.
Risk Management Plan Development & Implementation
Listen to the full podcast from UBC with PharmaVOICE here.
Are You Ready For Sentinel? | New RWE Safety Initiative
With continued investment in the RWE space, find out how to meet the needs of regulators, payers, and prescribers.
Immunogenicity: Meeting the Safety Reporting Requirements
Discover why it is imperative to assess the potential of therapeutic proteins throughout the product lifecycle.
DIA 2019: Watch the Wrap-up of UBC’s Participation
See more of the developments UBC’s evidence development and safety & risk management teams discussed.
Natalie O’Donnell, Head of Safety & Risk Management, Presents a REMS Overview
Learn more about mandatory Risk Evaluation and Mitigation Strategies programs.
